Edition:
United States

NxStage Medical Inc (NXTM.OQ)

NXTM.OQ on NASDAQ Stock Exchange Global Select Market

22.99USD
4:00pm EDT
Change (% chg)

$-0.15 (-0.65%)
Prev Close
$23.14
Open
$23.20
Day's High
$23.32
Day's Low
$22.93
Volume
182,960
Avg. Vol
170,964
52-wk High
$30.80
52-wk Low
$18.90

NXTM.OQ

Chart for NXTM.OQ

About

NxStage Medical, Inc. is a medical technology company. The Company develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. It operates through three segments. The System One segment includes revenues from the sale and rental of the System One and PureFlow SL dialysate... (more)

Overall

Beta: 0.10
Market Cap(Mil.): $1,521.12
Shares Outstanding(Mil.): 65.74
Dividend: --
Yield (%): --

Financials

  NXTM.OQ Industry Sector
P/E (TTM): -- 38.47 18.98
EPS (TTM): -0.07 -- --
ROI: -2.61 8.76 -5.09
ROE: -2.31 13.56 -4.32

BRIEF-Nxstage Medical announces FDA clearance for new system one hemodialysis system

* Nxstage Medical announces fda clearance for its new system one hemodialysis system

May 10 2017

BRIEF-NxStage Q1 revenue $96.8 million

* NxStage Medical Inc - revising annual home revenue growth target to be between 10 to 13 pct for 2017 versus previous 15 pct target

May 09 2017

BRIEF-NxStage Medical announces CE mark for its NxGen Hemodialysis System

* Nxstage medical announces ce mark for its nxgen hemodialysis system Source text for Eikon: Further company coverage:

Mar 02 2017

BRIEF-NxStage reports Q4 revenue of $93 million

* NxStage reports fourth quarter and full-year 2016 financial results

Feb 28 2017

More From Around the Web

Competitors

Earnings vs. Estimates